<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">New onset of HF was observed in as much as a quarter of hospitalized COVID-19 patients; and in as much as one-third of those admitted to the intensive care unit (ICU) [
 <xref ref-type="bibr" rid="CR17">17</xref>, 
 <xref ref-type="bibr" rid="CR19">19</xref>], despite not having a history of HF. This could be due to the direct effect of the virus or the systemic inflammation on the heart. Severe 
 <italic>acute myocarditis</italic> can be a manifestation of the infection resulting in cardiogenic shock, which can then result in multi-organ dysfunction syndrome (MODS) and death [
 <xref ref-type="bibr" rid="CR20">20</xref>]. Moreover, the prothrombotic state previously discussed can result in pulmonary embolism and thus acute right ventricular failure. The use of temporary heart pumps such as the Impella may be useful in these scenarios.
</p>
